1. Alendar, Andrej, Lambooij, Jan-Paul, Bhaskaran, Rajith, Snoek, Margriet, Berns, Anton. 2020. Gene expression regulation by the Chromodomain helicase DNA-binding protein 9 (CHD9) chromatin remodeler is dispensable for murine development. In PloS one, 15, e0233394. doi:10.1371/journal.pone.0233394. https://pubmed.ncbi.nlm.nih.gov/32453735/
2. Ooga, Masatoshi, Funaya, Satoshi, Hashioka, Yuki, Suzuki, Masataka G, Aoki, Fugaku. 2018. Chd9 mediates highly loosened chromatin structure in growing mouse oocytes. In Biochemical and biophysical research communications, 500, 583-588. doi:10.1016/j.bbrc.2018.04.105. https://pubmed.ncbi.nlm.nih.gov/29665362/
3. Song, Dan, Zhang, Qian, Zhang, Hao, Zhan, Liangliang, Sun, Xinchen. 2022. MiR-130b-3p promotes colorectal cancer progression by targeting CHD9. In Cell cycle (Georgetown, Tex.), 21, 585-601. doi:10.1080/15384101.2022.2029240. https://pubmed.ncbi.nlm.nih.gov/35100082/
4. Newton, Axel H, Pask, Andrew J. 2020. CHD9 upregulates RUNX2 and has a potential role in skeletal evolution. In BMC molecular and cell biology, 21, 27. doi:10.1186/s12860-020-00270-5. https://pubmed.ncbi.nlm.nih.gov/32295522/
5. Xia, Tianfang, Pan, Zhenguo, Zhang, Jie. 2020. CircPDZD8 promotes gastric cancer progression by regulating CHD9 via sponging miR-197-5p. In Aging, 12, 19352-19364. doi:10.18632/aging.103805. https://pubmed.ncbi.nlm.nih.gov/33049714/
6. Guan, Bo, Ran, Xian-Gui, Du, Yong-Qiang, Wang, Ying, Chen, Ming-Min. 2018. High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma. In International journal of clinical and experimental pathology, 11, 3697-3702. doi:. https://pubmed.ncbi.nlm.nih.gov/31949752/
7. Salomon-Kent, Ronit, Marom, Ronit, John, Sam, Benayahu, Dafna, Hager, Gordon L. . New Face for Chromatin-Related Mesenchymal Modulator: n-CHD9 Localizes to Nucleoli and Interacts With Ribosomal Genes. In Journal of cellular physiology, 230, 2270-80. doi:10.1002/jcp.24960. https://pubmed.ncbi.nlm.nih.gov/25689118/
智鼠故事 
